Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Short Report
  • Published:

Effect of p21waf1/cip1 transgene on radiation induced apoptosis in T cells

Abstract

The cyclin kinase inhibitor p21WAF1/Cip1 is upregulated by the tumor suppressor p53. While p21 is central for the G-1 arrest mediated by p53, it is still unclear if p21 also functions as a downstream effector of p53 dependent apoptosis. Apoptosis induced by DNA damage but not dexamethasone is p53 dependent in thymocytes. To investigate the physiological role of p21 in apoptosis, we have generated transgenic mice in which the p21 transgene is targeted for restricted expression in the T cell lineage. Thymocytes from p21 transgenic mice were hypersensitive to cell death induced by DNA damaging agents such as ionizing radiation and UV, but not be dexamethasone. Irradiated p21 transgenic thymocytes had approximately twofold more apoptotic cells as compared to irradiated age matched littermate control mice. Radiation induced death is comparable in thymocytes from p21+Bcl2+double transgenic mice and age matched littermate controls, indicating that the Bcl2 transgene rescues the radiation hypersensitivity imposed by p21. However, thymocytes from p53−/− mice even when they expressed the p21 transgene, were resistant to death induced by radiation. Together these results show that thymocytes from p21 transgenic mice are hypersensitive to radiation induced programmed cell death and suggest that the radiation hypersensitivity of p21 transgenic thymocytes involves p53 dependent pathway and signals in addition to p21.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  • Abraham KM, Levin SD, Martin JD, Forbush KA and Perlmutter RM. . 1991 Proc. Natl. Acad. Sci. USA 88: 3977–3981.

  • Brady HJ, Salomons GS, Bobeldijk R and Berns AJ. . 1996 EMBO J. 15: 1221–1230.

  • Brenot-Bosc F, Gupta S, Margolis RL and Fotedar R. . 1995 Chromosoma 103: 517–527.

  • Brown JP, Wei W and Sedivy JM. . 1997 Science 277: 831–834.

  • Brugarolas J, Chandrasekaran C, Gordon JI, Beach D, Jacks T and Hannon GJ. . 1995 Nature 377: 552–557.

  • Chen U, Chen S, Saha P and Dutta A. . 1996 Proc. Natl. Acad. Sci. USA 93: 11597–11602.

  • Clarke AR, Purdie CA, Harrison DJ, Morris RG, Bird CC, Hooper ML and Wyllie AH. . 1993 Nature 362: 849–852.

  • Deng C, Zhang P, Harper JW, Elledge SJ and Leder P. . 1995 Cell 82: 675–684.

  • Dulic V, Kaufmann WK, Wilson SJ, Tlsty TD, Lees E, Harper JW, Elledge SJ and Reed SI. . 1994 Cell 76: 1013–1023.

  • Duttaroy A, Qian JF, Smith JS and Wang E. . 1997 J. Cell. Biochem. 64: 434–446.

  • El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW and Vogelstein B. . 1993 Cell 75: 817–825.

  • Fotedar R, Fitzgerland P, Rousselle T, Cannella D, Doree M, Messier H and Fotedar A. . 1996 Oncogene 12: 2155–2164.

  • Fotedar R, Flatt J, Gupta S, Margolis RL, Fitzgerald P, Messier H and Fotedar A. . 1995 Mol. Cell. Biol. 15: 932–942.

  • Garvin AM, Abraham KM, Forbush KA, Farr AG, Davison BL and Perlmutter RM. . 1990 Int. Immunol. 2: 173–180.

  • Gorospe M, Cirielli C, Wang X, Seth P, Capogrossi MC and Holbrook NJ. . 1997 Oncogene 14: 929–935.

  • Hakem R, Hakem A, Duncan GS, Henderson JT, Woo M, Soengas MS, Elia A, Pompa JL, Kagi D, Khoo W, Potter J, Yoshida R, Kaufman SA, Lowe SW, Penninger JM and Mak TW. . 1998 Cell 94: 339–352.

  • Halevy O, Novitch BG, Spicer DB, Skapek SX, Rhee J, Hannon GJ, Beach D and Lassar AB. . 1995 Science 267: 1018–1021.

  • Hannon GJ and Beach D. . 1994 Nature 371: 257–261.

  • Harper JW, Adami G, Wei N, Keyomarsi K and Elledge SJ. . 1993 Cell 75: 805–816.

  • Jacks T, Remington L, Williams BO, Schmitt EM, Halachmi S, Bronson RT and Weinberg RA. . 1994 Curr. Biol. 4: 1–7.

  • Katsumata M, Siegel RM, Louie DC, Miyashita T, Tsujimoto Y, Nowell PC, Greene MI and Reed JC. . 1992 Proc. Natl. Acad. Sci. USA 89: 11376–11380.

  • Kearsey JM, Coates PJ, Prescott AR, Warbrick E and Hall PA. . 1995 Oncogene 11: 1675–1683.

  • Knudson CM, Tung KS, Tourtellotte WG, Brown GA and Korsmeyer SJ. . 1995 Science 270: 96–99.

  • Kondo Y, Kondo S, Liu J, Haqqi T, Barnett GH and Barna BP. . 1997 Exp. Cell. Res. 236: 51–56.

  • Kuida K, Haydar TF, Kuan C-Y, Gu Y, Taya C, Karasuyama H, Du MS-S, Rakic P and Flavell RA. . 1998 Cell 94: 325–337.

  • Lee MH, Reynisdottir I and Massague J. . 1995 Genes Dev. 9: 639–649.

  • Li R, Waga S, Hannon GJ, Beach D and Stillman B. . 1994 Nature 371: 534–537.

  • Linton PJ, Haynes L, Klinman NR and Swain SL. . 1996 J. Exp. Med. 184: 1891–1900.

  • Lowe SW, Schmitt EM, Smith SW, Osborne BA and Jacks T. . 1993 Nature 362: 847–849.

  • Luo Y, Hurwitz J and Massague J. . 1995 Nature 375: 159–161.

  • Macleod KF, Sherry N, Hannon G, Beach D, Tokino T, Kinzler K, Vogelstein B and Jacks T. . 1995 Genes Dev. 9: 935–944.

  • Matsuoka S, Edwards MC, Bai C, Parker S, Zhang P, Baldini A, Harper JW and Elledge SJ. . 1995 Genes Dev. 9: 650–662.

  • McDonald ER, Wu G, Waldman T and El-Deiry WS. . 1996 Cancer Res. 56: 2250–2255.

  • Miyashita T and Reed JC. . 1995 Cell 80: 293–299.

  • Oltvai ZN, Milliman CL and Korsmeyer SJ. . 1993 Cell 74: 609–619.

  • Pan ZQ, Reardon JT, Li L, Flores-Rozas H, Legerski R, Sancar A and Hurwitz J. . 1995 J. Biol. Chem. 270: 22008–22016.

  • Polyak K, Lee MH, Erdjument-Bromage H, Koff A, Roberts JM, Tempst P and Massague J. . 1994 Cell 78: 59–66.

  • Sekiguchi T and Hunter T. . 1998 Oncogene 16: 369–380.

  • Sentman CL, Shutter JR, Hockenbery D, Kanagawa O and Korsmeyer SJ. . 1991 Cell 67: 879–888.

  • Sheikh MS, Chen Y, Smith ML and Fornace Jr AJ. . 1997 Oncogene 14: 1875–1882.

  • Sherr CJ and Roberts JM. . 1995 Gene Dev. 9: 1149–1163.

  • Shivji MK, Grey SJ, Strausfeld UP, Wood RD and Blow JJ. . 1994 Curr. Biol. 4: 1062–1068.

  • Strasser A, Harris AW, Jacks T and Cory S. . 1994 Cell 79: 329–339.

  • Toyoshima H and Hunter T. . 1994 Cell 78: 67–74.

  • Umar A, Buermeyer AB, Simon JA, Thomas DC, Clark AB, Liskay RM and Kunkel TA. . 1996 Cell 87: 65–73.

  • Yoshida H, Kong Y-Y, Yoshida R, Elia AJ, Halem A, Halem R, Penninger JM and Mak TW. . 1998 Cell 94: 739–750.

  • Waldman T, Lengauer C, Kinzler KW and Vogelstein B. . 1996 Nature 381: 713–716.

  • Wu H, Wade M, Krall L, Grisham J, Xiong Y and Van Dyke T. . 1996 Genes Dev. 10: 245–260.

  • Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R and Beach D. . 1993 Nature 366: 701–704.

Download references

Acknowledgements

We acknowledge the generous gift of p53 null mice by Tyler Jacks (Massachusetts Institute of Technology) and the p1017 transgenic vector by R Perlmutter (University of Washington). The authors acknowledge H Messier for cloning p21, J Price for oocyte microinjections, and P Linton for purifying splenic T and B cells. The authors also acknowledge the dedicated technical help by V Barbier, V Marrell and P Fitzgerald. A Fotedar thanks T Hunter for a helpful discussion. We thank Dr R Margolis for critically reading this manuscript. T Rousselle and L Diederich were supported by a studentship and a fellowship respectively from Region Rhône Alpes. This work was supported by grants to R Fotedar from the Region Rhône Alpes [HO9873.08.12], and l'Association pour la Recherche sur le Cancer [6675] and by grants to A Fotedar from the American Cancer Society [DB107] and the National Institutes of Health [AI31453 and CA74435].

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fotedar, R., Brickner, H., Saadatmandi, N. et al. Effect of p21waf1/cip1 transgene on radiation induced apoptosis in T cells. Oncogene 18, 3652–3658 (1999). https://doi.org/10.1038/sj.onc.1202693

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1202693

Keywords

This article is cited by

Search

Quick links